Veterinary Dermatology Drugs Market

Global Veterinary Dermatology Drugs Market Size, Trends & Analysis - Forecasts to 2026 By Product Type (Antifungal Drugs, Antibacterial Drugs, Antiparasitic Drugs, Others), By Animal Type (Companion Animal, Livestock Animal), By Route of Administration (Oral, Topical, Injectable), By Indication (Parasitic Infections, Allergic Infections, Others), By Distribution Channel (Retail, E-Commerce, Hospital Pharmacies), By Region (North America, Asia Pacific, CSA, Europe, and the Middle East and Africa), Competitive Landscape Company Market Share Analysis, and Competitor Analysis

Category Healthcare
Format
  • ms word
  • ms excel
  • ms ppt
  • pdf
This report was recently updated on February 15 2024 with the latest and most recent market numbers

Veterinary Dermatology Drugs Market Size

The global veterinary dermatology drugs market is projected to grow from USD 7.6 billion in 2021 to USD 11.6 billion by 2026 at a CAGR value of 9.5% between 2021 to 2026. Veterinary dermatology is the management, detection, and treatment of chronic conditions, dysfunction, and damage in animals. The scope of veterinary dermatology is broad, encompassing all animal species, both domesticated and wild, as well as a comprehensive list of disorders that may affect specific species.

The rising prevalence of skin diseases in animals, as well as high investments made by top market players in this domain, are the prime factors expected to drive the market growth. The industry has witnessed a trend of pet owners making more pet care decisions, which is expected to boost the market growth.

Dermatological concerns now account for even more than 20% of all veterinarian consultations for animals. Allergies, otitis externa, seborrheic dermatitis, and surface pyoderma are the most common chronic dermatological diseases. Launch of advanced medical devices and equipments and rising number of research publications related to veterinary dermatology in order to detect and treat serious skin diseases are supporting the market growth. As a result, the increase in veterinarian consultation visits is expected to contribute to the growth of the global veterinary dermatology medications market during the forecast period.

The increased frequency of skin disorders in animals, as well as increasing investment in the industry by veterinary drug companies, are projected to fuel market expansion. The pet care industry has seen a rising trend of pet owners adopting more pet treatment choices, which is also projected to drive market growth.

The COVID-19 epidemic continues to wreak havoc the veterinary industry, with the global veterinary dermatological pharmaceuticals market anticipated to suffer until the end of 2021. Cashless payment handling, computerized data transfer, and drive-thru pick-up and drop-off are among all the other administrative innovations to manage veterinary care. However, rapid vaccination dissemination and launch of enhanced medical device and equipments are projected to increase the global veterinary dermatology drugs market growth rate post 2021.

global veterinary dermatology drugs market

Veterinary Dermatology Drugs Market: By Product Type

Based on the product type, the market is segmented into antifungal drugs, antibacterial drugs, antiparasitic drugs, others. The antifungal drugs segment is expected to have the largest share in the market during the forecast period. Several antifungal medicines are being primarily used to treat skin disorders in animals. Rising awareness of efficient and enhanced treatment alternatives will drive the segment growth.

Veterinary Dermatology Drugs Market: By Animal Type

Based on the animal type, the market is divided into companion animal and livestock animal. The companion animal segment is anticipated to have the largest share in the market during the forecast period. Increased pet ownership is likely to drive market expansion. The category is even further subdivided into dogs, cats, horses, and other animals. The dogs' category is predicted to hold the largest market share due to the wide availability of treatments for the rehabilitation of dogs.

Veterinary Dermatology Drugs Market: By Route of Administration

Based on the route of administration, the market is segmented into oral, topical, and injectable. The oral segment is anticipated to witness the largest share in the market during the forecast period. The widespread availability of oral medications in the type of tablets, pills, and feed additives, among many other things, are expected propel market expansion.

Veterinary Dermatology Drugs Market: By Indication

Based on indication, the market is segmented into parasitic infections, allergic infections, others. The parasitic infections segment is expected to have the largest share in the market during the forecast period. Rising prevalence of parasite disorders is likely to drive market expansion.

The market for allergic infections is also expected to grow rapidly during the forecast period. The rising frequency of ailments including atopic dermatitis as well as other itchy conditions, particularly in companion animals, is projected to drive market growth. Moreover, more dog owners making pet care decisions are likely to drive market growth.

Veterinary Dermatology Drugs Market: By Distribution Channel

Based on the distribution channel, the market is segmented into retail, e-commerce, hospital pharmacies. The hospital pharmacies segment is anticipated to hold the largest market share during the forecast period. The increasing number of healthcare pharmacies is likely to drive the segment's growth. Furthermore, when it comes to the rehabilitation of domestic pets or farm animals, animal owners prefer to diagnostic approach for any kind of treatment or disease screening. As a result, hospital pharmacies are the primary venues for purchasing recommended medications, giving them a commanding market share.

asia pacific veterinary dermatology drugs market

Veterinary Dermatology Drugs Market: By Region

Based on region, the market can be segmented into various regions such as North America, Europe, Central, and South America, the Middle East and Africa, and Asia Pacific regions. The North American region is expected to have a lion’s share in the market during the forecast period. Rising number of measures by the government and business sector, increasing pet care expenditures, and the rising number of large stakeholders is all fuelling the region’s growth. Further, the increased prevalence of zoonotic illnesses is likely to fuel market growth.

The Asia Pacific region is also expected to grow rapidly during the forecast period. The Asia Pacific veterinary dermatology drugs market is expected to rise significantly during the forecast period of 2021 to 2026, owing to factors such as rising consumption for veterinary dermatology drugs and a increasing awareness of vet drugs and medicines' in emerging nations like India and China.

Veterinary Dermatology Drugs Market Share and Competitor Analysis

Elanco, Merck & Co Inc., Zoetis, Vetoquinol S.A., Ceva, Virbac, Bioiberica S.A.U, Bimeda, Inc., Indian Immunologicals Ltd., Vivaldis, among others, are the key players in the veterinary dermatology drugs market.

Please note: This is not an exhaustive list of companies profiled in the report.

Chapter 1   Methodology

1.1    Market Scope & Definitions

1.2    Estimates & Forecast Calculation

1.3    Historical Data Overview and Validation

1.4    Data Sources

1.4.1    Secondary

1.4.2    Primary

Chapter 2   Report Outlook

2.1    Veterinary Dermatology Drugs Industry Overview, 2020-2026

2.1.1    Industry Overview

2.1.2    Product Type Overview

2.1.3    Animal Type Overview

2.1.4    Route of Administration Overview

2.1.5    Indication Overview

2.1.6    Distribution Channel Overview

2.1.7    Regional Overview

Chapter 3   Veterinary Dermatology Drugs Market Trends

3.1    Market Segmentation

3.2    Industry Background, 2020-2026

3.3    Market Key Trends

3.3.1    Positive Trends

3.3.1.1    Rising prevelance of skin disorders in animals

3.3.2    Industry Challenges

3.3.2.1    Non-supportive government norms related to medical insurance

3.4    Prospective Growth Scenario

3.4.1    Product Type Growth Scenario

3.4.2    Animal Type Growth Scenario

3.4.3    Route of Administration Growth Scenario

3.4.4    Indication Growth Scenario

3.4.5    Distribution Channel Growth Scenario

3.5    COVID-19 Influence over Industry Growth

3.6    Porter’s Analysis

3.7    PESTEL Analysis

3.8    Value Chain & Supply Chain Analysis

3.9    Regulatory Framework

3.9.1    North America

3.9.2    Europe

3.9.3    APAC

3.9.4    LATAM

3.9.5    MEA

3.10    Indication Overview

3.11    Market Share Analysis, 2020

3.11.1    Company Positioning Overview, 2020

Chapter 4   Veterinary Dermatology Drugs Market, By Product Type

4.1    Product Type Outlook

4.2    Antifungal Drugs

4.2.1    Market Size, By Region, 2020-2026 (USD Billion)

4.3    Antibacterial Drugs

4.3.1    Market Size, By Region, 2020-2026 (USD Billion)

4.4    Antiparasitic Drugs

4.4.1    Market Size, By Region, 2020-2026 (USD Billion)

4.5    Others

4.5.1    Market Size, By Region, 2020-2026 (USD Billion)

Chapter 5   Veterinary Dermatology Drugs Market, By Route of Administration

5.1    Route of Administration Outlook

5.2    Oral

5.2.1    Market Size, By Region, 2020-2026 (USD Billion)

5.3    Topical

5.3.1    Market Size, By Region, 2020-2026 (USD Billion)

5.4    Injectable

5.4.1    Market Size, By Region, 2020-2026 (USD Billion)

Chapter 6   Veterinary Dermatology Drugs Market, By Animal Type

6.1    Companion Animal

6.1.1    Market Size, By Region, 2020-2026 (USD Billion)

6.2    Livestock Animal

6.2.1    Market Size, By Region, 2020-2026 (USD Billion)

Chapter 7   Veterinary Dermatology Drugs Market, By Indication

7.1    Parasitic Infections

7.1.1    Market Size, By Region, 2020-2026 (USD Billion)

7.2    Allergic Infections

7.2.1    Market Size, By Region, 2020-2026 (USD Billion)

7.3    Others

7.3.1    Market Size, By Region, 2020-2026 (USD Billion)

Chapter 8   Veterinary Dermatology Drugs Market, By Distribution Channel

8.1    Retail

8.1.1    Market Size, By Region, 2020-2026 (USD Billion)

8.2    E-Commerce

8.2.1    Market Size, By Region, 2020-2026 (USD Billion)

8.3    Hospital Pharmacies

8.3.1    Market Size, By Region, 2020-2026 (USD Billion)

Chapter 9   Veterinary Dermatology Drugs Market, By Region

9.1    Regional outlook

9.2    North America

9.2.1    Market Size, By Country 2020-2026 (USD Billion)

9.2.2    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.2.3    Market Size, By Offering Type, 2020-2026 (USD Billion)

9.2.4    Market Size, By Route of Administration, 2020-2026 (USD Billion)

9.2.5    Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.2.6    U.S.

9.2.6.1    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.2.4.2    Market Size, By Offering Type, 2020-2026 (USD Billion)

9.2.4.3    Market Size, By Route of Administration, 2020-2026 (USD Billion)

Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.2.7    Canada

9.2.7.1    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.2.7.2    Market Size, By Offering Type, 2020-2026 (USD Billion)

9.2.7.3    Market Size, By Route of Administration, 2020-2026 (USD Billion)

9.2.7.4    Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.3    Europe

9.3.1    Market Size, By Country 2020-2026 (USD Billion)

9.3.2    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.3.3    Market Size, By Offering Type, 2020-2026 (USD Billion)

9.3.4    Market Size, By Route of Administration, 2020-2026 (USD Billion)

9.3.5    Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.3.6    Market Size, By End-User, 2020-2026 (USD Billion)

9.3.7    Germany

9.3.7.1    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.3.7.2    Market Size, By Offering Type, 2020-2026 (USD Billion)

9.3.7.3    Market Size, By Route of Administration, 2020-2026 (USD Billion)

9.3.7.4    Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.3.7.5    Market Size, By End-User, 2020-2026 (USD Billion)

9.3.8    UK

9.3.8.1    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.3.8.2    Market Size, By Offering Type, 2020-2026 (USD Billion)

9.3.8.3    Market Size, By Route of Administration, 2020-2026 (USD Billion)

9.3.8.4    Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.3.8.5    Market Size, By End-User, 2020-2026 (USD Billion)

9.3.9    France

9.3.9.1    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.3.9.2    Market Size, By Offering Type, 2020-2026 (USD Billion)

9.3.9.3    Market Size, By Route of Administration, 2020-2026 (USD Billion)

9.3.9.4    Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.3.9.5    Market Size, By End-User, 2020-2026 (USD Billion)

9.3.10    Italy

9.3.10.1    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.3.10.2    Market Size, By Offering Type, 2020-2026 (USD Billion)

9.3.10.3    Market Size, By Route of Administration, 2020-2026 (USD Billion)

9.3.10.4    Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.3.10.5    Market Size, By End-User, 2020-2026 (USD Billion)

9.3.11    Spain

9.3.11.1    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.3.11.2    Market Size, By Offering Type, 2020-2026 (USD Billion)

9.3.11.3    Market Size, By Route of Administration, 2020-2026 (USD Billion)

9.3.11.4    Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.3.11.5    Market Size, By End-User, 2020-2026 (USD Billion)

9.3.12    Russia

9.3.12.1    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.3.12.2    Market Size, By Offering Type, 2020-2026 (USD Billion)

9.3.12.3    Market Size, By Route of Administration, 2020-2026 (USD Billion)

9.3.12.4    Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.3.12.5    Market Size, By End-User, 2020-2026 (USD Billion)

9.4    Asia Pacific

9.4.1    Market Size, By Country 2020-2026 (USD Billion)

9.4.2    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.4.3    Market Size, By Offering Type, 2020-2026 (USD Billion)

9.4.4    Market Size, By Route of Administration, 2020-2026 (USD Billion)

9.4.5   Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.3.6    Market Size, By End-User, 2020-2026 (USD Billion)

9.4.7    China

9.4.7.1    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.4.7.2    Market Size, By Offering Type, 2020-2026 (USD Billion)

9.4.7.3    Market Size, By Route of Administration, 2020-2026 (USD Billion)

9.4.7.4    Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.4.7.5    Market Size, By End-User, 2020-2026 (USD Billion)

9.4.8    India

9.4.8.1    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.4.8.2    Market Size, By Offering Type, 2020-2026 (USD Billion)

9.4.8.3    Market Size, By Route of Administration, 2020-2026 (USD Billion)

9.4.8.4    Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.4.8.5    Market Size, By End-User, 2020-2026 (USD Billion)

9.4.9    Japan

9.4.9.1    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.4.9.2    Market Size, By Offering Type, 2020-2026 (USD Billion)

9.4.9.3    Market Size, By Route of Administration, 2020-2026 (USD Billion)

9.4.9.4    Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.4.9.5    Market Size, By End-User, 2020-2026 (USD Billion)

9.4.10    Australia

9.4.10.1    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.4.10.2    Market size, By Offering Type, 2020-2026 (USD Billion)

9.4.10.3    Market Size, By Route of Administration, 2020-2026 (USD Billion)

9.4.10.4    Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.4.10.5    Market Size, By End-User, 2020-2026 (USD Billion)

9.4.11    South Korea

9.4.11.1    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.4.11.2    Market Size, By Offering Type, 2020-2026 (USD Billion)

9.4.11.3    Market Size, By Route of Administration, 2020-2026 (USD Billion)

9.4.11.4    Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.3.7.5    Market Size, By End-User, 2020-2026 (USD Billion)

9.5    Latin America

9.5.1    Market Size, By Country 2020-2026 (USD Billion)

9.5.2    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.5.3    Market Size, By Offering Type, 2020-2026 (USD Billion)

9.5.4   Market Size, By Route of Administration, 2020-2026 (USD Billion)

9.5.5   Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.5.6    Market Size, By End-User, 2020-2026 (USD Billion)

9.5.7    Brazil

9.5.7.1    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.5.7.2    Market Size, By Offering Type, 2020-2026 (USD Billion)

9.5.7.3    Market Size, By Route of Administration, 2020-2026 (USD Billion)

9.5.7.4    Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.5.7.5    Market Size, By End-User, 2020-2026 (USD Billion)

9.5.8    Mexico

9.5.8.1    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.5.8.2    Market Size, By Offering Type, 2020-2026 (USD Billion)

9.5.8.3    Market Size, By Route of Administration, 2020-2026 (USD Billion)

9.5.8.4    Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.3.7.5    Market Size, By End-User, 2020-2026 (USD Billion)

9.5.9    Argentina

9.5.9.1    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.5.9.2    Market Size, By Offering Type, 2020-2026 (USD Billion)

9.5.9.3    Market Size, By Route of Administration, 2020-2026 (USD Billion)

9.5.9.4    Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.3.7.5    Market Size, By End-User, 2020-2026 (USD Billion)

9.6    MEA

9.6.1    Market Size, By Country 2020-2026 (USD Billion)

9.6.2    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.6.3    Market Size, By Offering Type, 2020-2026 (USD Billion)

9.6.4    Market Size, By Route of Administration, 2020-2026 (USD Billion)

9.6.5    Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.6.6    Market Size, By End-User, 2020-2026 (USD Billion)

9.6.7    Saudi Arabia

9.6.7.1    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.6.7.2    Market Size, By Offering Type, 2020-2026 (USD Billion)

9.6.7.3   Market Size, By Route of Administration, 2020-2026 (USD Billion)

9.6.7.4   Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.6.7.5    Market Size, By End-User, 2020-2026 (USD Billion)

9.6.8    UAE

9.6.8.1    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.6.8.2    Market Size, By Offering Type, 2020-2026 (USD Billion)

9.6.8.3    Market Size, By Route of Administration, 2020-2026 (USD Billion)

9.6.8.4    Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.6.8.5    Market Size, By End-User, 2020-2026 (USD Billion)

9.6.9    South Africa

9.6.9.1    Market Size, By Deployment Type, 2020-2026 (USD Billion)

9.6.9.2    Market Size, By Offering Type, 2020-2026 (USD Billion)

9.6.9.3    Market Size, By Route of Administration, 2020-2026 (USD Billion)

9.6.9.4    Market Size, By Project Lifecycle, 2020-2026 (USD Billion)

9.6.9.5    Market Size, By End-User, 2020-2026 (USD Billion)

Chapter 9   Company Landscape

10.1    Competitive Analysis, 2020

10.2   Elanco, Merck & Co Inc.

10.2.1    Company Overview

10.2.2    Financial Analysis

10.2.3    Strategic Positioning

10.2.4    Info Graphic Analysis

10.3    Zoetis

10.3.1    Company Overview

10.3.2    Financial Analysis

10.3.3    Strategic Positioning

10.3.4    Info Graphic Analysis

10.4    Vetoquinol S.A.

10.4.1    Company Overview

10.4.2    Financial Analysis

10.4.3    Strategic Positioning

10.4.4    Info Graphic Analysis

10.5    Ceva

10.5.1    Company Overview

10.5.2    Financial Analysis

10.5.3    Strategic Positioning

10.5.4    Info Graphic Analysis

10.6    Virbac

10.6.1    Company Overview

10.6.2    Financial Analysis

10.6.3    Strategic Positioning

10.6.4    Info Graphic Analysis

10.7   Bioiberica S.A.U

10.7.1    Company Overview

10.7.2    Financial Analysis

10.7.3    Strategic Positioning

10.7.4    Info Graphic Analysis

10.8    Bimeda, Inc

10.8.1    Company Overview

10.8.2    Financial Analysis

10.8.3    Strategic Positioning

10.8.4    Info Graphic Analysis

10.9    Indian Immunologicals Ltd

10.9.1    Company Overview

10.9.2    Financial Analysis

10.9.3    Strategic Positioning

10.9.4    Info Graphic Analysis

10.10    Vivaldis

10.10.1    Company Overview

10.10.2    Financial Analysis

10.10.3    Strategic Positioning

10.10.4    Info Graphic Analysis

10.11    Other Companies

10.11.1    Company Overview

10.11.2    Financial Analysis

10.11.3    Strategic Positioning

10.11.4    Info Graphic Analysis

The Global Veterinary Dermatology Drugs Market has been studied from the year 2019 till 2026. However, the CAGR provided in the report is from the year 2021 to 2026. The research methodology involved three stages: Desk research, Primary research, and Analysis & Output from the entire research process.

The desk research involved a robust background study which meant referring to paid and unpaid databases to understand the market dynamics; mapping contracts from press releases; identifying the key players in the market, studying their product portfolio, competition level, annual reports/SEC filings & investor presentations; and learning the demand and supply-side analysis for the Veterinary Dermatology Drugs Market.

The primary research activity included telephonic conversations with more than 50 tier 1 industry consultants, distributors, and end-use product manufacturers.

Finally, based on the above thorough research process, an in-depth analysis was carried out considering the following aspects: market attractiveness, current & future market trends, market share analysis, SWOT analysis of the company and customer analytics.

We value your investment and offer free customization with every report to fulfil your exact research needs.
This website is secure and your personal details are safe. Privacy
You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The global veterinary dermatology drugs market is projected to grow from USD 7.6 billion in 2021 to USD 11.6 billion by 2026 at a CAGR value of 9.5% between 2021 to 2026.
Elanco, Merck & Co Inc., Zoetis, Vetoquinol S.A., Ceva, Virbac, Bioiberica S.A.U, Bimeda, Inc., Indian Immunologicals Ltd., Vivaldis, among others, are the key players in the veterinary dermatology drugs market.
The North American region is estimated to hold the largest share of the veterinary dermatology drugs market.
The COVID-19 epidemic continues to wreak havoc the veterinary industry, with the global veterinary dermatological pharmaceuticals market anticipated to suffer until the end of 2021. Cashless payment handling, computerized data transfer, and drive-thru pick-up and drop-off are among all the other administrative innovations to manage veterinary care. However, rapid vaccination dissemination and launch of enhanced medical device and equipments are projected to increase the global veterinary dermatology drugs market growth rate post 2021.
The rising prevalence of skin diseases in animals, as well as high investments made by top market players in this domain, are the prime factors expected to drive the market growth. The industry has witnessed a trend of pet owners making more pet care decisions, which is expected to boost the market growth.

Tailor made solutions just for you

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

OUR CLIENTS

  • Client of Global Market Estimates - Fedex
  • Client of Global Market Estimates - Samsung
  • Client of Global Market Estimates - Siemens
  • Client of Global Market Estimates - Lonza
  • Client of Global Market Estimates - DuPont
  • Client of Global Market Estimates - Medtronic
  • Client of Global Market Estimates - Toray
  • Client of Global Market Estimates - Signify
  • Client of Global Market Estimates - Teledyne
  • Client of Global Market Estimates - Trelleborg
  • Client of Global Market Estimates - Kikkoman Biochemifa
  • Client of Global Market Estimates - Leoni
  • Client of Global Market Estimates - Molnlycke
  • Client of Global Market Estimates - Spirent
  • Client of Global Market Estimates - Tokyo Electron Limited
  • Client of Global Market Estimates - Aranca
  • Client of Global Market Estimates - Asahi Kasei
  • Client of Global Market Estimates - Chimai
  • Client of Global Market Estimates - Grapsud
  • Client of Global Market Estimates - Horiba
  • Client of Global Market Estimates - Indorama
  • Client of Global Market Estimates - L&T
  • Client of Global Market Estimates - Integralife
  • Client of Global Market Estimates - Synamedia
  • Client of Global Market Estimates - Sorrento Therapeutics
  • Client of Global Market Estimates - Solenis
  • Client of Global Market Estimates - Sartorius